(Q33872936)

29 July 2017

Impact of immunomodulating therapy on morbidity in patients with severe sepsis (English)

1 reference

29 July 2017

0 references

1

Pittet D

1 reference

29 July 2017

Harbarth S

2

1 reference

29 July 2017

Suter PM

3

1 reference

29 July 2017

Reinhart K

4

1 reference

29 July 2017

Leighton A

5

1 reference

29 July 2017

Barker C

6

1 reference

29 July 2017

Macdonald F

7

1 reference

29 July 2017

Abraham E

8

1 reference

29 July 2017

language of work or name

English

0 references

publication date

1 September 1999

1 reference

American Journal of Respiratory and Critical Care Medicine

29 July 2017

1 reference

29 July 2017

160

1 reference

29 July 2017

852-857

1 reference

29 July 2017

3

1 reference

The risk factors, incidence, and prognosis of ARDS following septicemia

29 July 2017

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.160.3.9809033

Septic shock in humans. Advances in the understanding of pathogenesis, cardiovascular dysfunction, and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.160.3.9809033

The natural history of the systemic inflammatory response syndrome (SIRS). A prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.160.3.9809033

Bedside prediction of mortality from bacteremic sepsis. A dynamic analysis of ICU patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.160.3.9809033

Activation of coagulation after administration of tumor necrosis factor to normal subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.160.3.9809033

Tumor necrosis factor and disease severity in children with falciparum malaria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.160.3.9809033

TNF concentration in fatal cerebral, non-fatal cerebral, and uncomplicated Plasmodium falciparum malaria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.160.3.9809033

Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.160.3.9809033

Efficacy and safety of monoclonal antibody to human tumor necrosis factor alpha in patients with sepsis syndrome. A randomized, controlled, double-blind, multicenter clinical trial. TNF-alpha MAb Sepsis Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.160.3.9809033

Assessment of the safety and efficacy of the monoclonal anti-tumor necrosis factor antibody-fragment, MAK 195F, in patients with sepsis and septic shock: a multicenter, randomized, placebo-controlled, dose-ranging study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.160.3.9809033

INTERSEPT: an international, multicenter, placebo-controlled trial of monoclonal antibody to human tumor necrosis factor-alpha in patients with sepsis. International Sepsis Trial Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.160.3.9809033

Protection against rat endotoxic shock by p55 tumor necrosis factor (TNF) receptor immunoadhesin: comparison with anti-TNF monoclonal antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.160.3.9809033

The effects of ibuprofen on the physiology and survival of patients with sepsis. The Ibuprofen in Sepsis Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.160.3.9809033

Cost-effectiveness of HA-1A monoclonal antibody for gram-negative sepsis. Economic assessment of a new therapeutic agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.160.3.9809033

Should morbidity replace mortality as an endpoint for clinical trials in intensive care?

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.160.3.9809033

A simple multiple system organ failure scoring system predicts mortality of patients who have sepsis syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.160.3.9809033

Nonparametric Estimation from Incomplete Observations

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.160.3.9809033

The prevalence of nosocomial infection in intensive care units in Europe. Results of the European Prevalence of Infection in Intensive Care (EPIC) Study. EPIC International Advisory Committee

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.160.3.9809033

Analysis and interpretation of treatment effects in subgroups of patients in randomized clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.160.3.9809033

10.1164/AJRCCM.160.3.9809033

21 January 2018

Identifiers

DOI

1 reference

29 July 2017

1 reference